NFE2L2 and breast cancer: BCRP has been reported to induce drug resistant phenotype of NRF2 dependance by increasing the efflux of 5-FU in breast cancer cells[33] and Irinotecan, Topotecan and Mitoxantrone in colorectal cancer cells[32,34].